Long-Term Surveillance of Bladder Tumours: Current Practice in the United Kingdom and Ireland

Wazait, H.D.; Al-Bhueissi, S.Z.; Patel, Himanshu; Nathan, Miriam; Miller, Ronald

doi:10.1016/s0302-2838(03)00052-6

Cited by 5 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study (which was not included in our review as it was published prior to the year 2000), also supported the surveillance of TaG1 patients beyond five years stating that progression was not uncommon for these patients (23). Furthermore, almost half of the clinicians surveyed within the qualitative study by Wazait et al said that they continue surveillance for these patients for 10 years with 18% saying this surveillance should be lifelong (22). On the contrary, the study by Mariappan and Smith recommended that patients with G1Ta disease who remain free of recurrence for five years after presentation can be safely discharged from further surveillance (10).…”

Section: Discussionmentioning

confidence: 58%

“…A small minority reported that they would wait a year before performing the next cystoscopy (28% in pTa and 16% in pT1 G1/G2 tumours). Similarly, the study by Wazait et al looked at pTa and pT1 tumours separately (22). In this study however, they found that consultant urologists tended to carry on the cystoscopy follow-up of pT1 patients for longer than pTa tumours.…”

Section: Resultsmentioning

confidence: 76%

“…There were also some discrepancies between a recommendation to continue or cease endoscopic follow-up after a five-year period and as to which patients this would be recommended for. This was particularly evident in the survey of consultant urologists conducted by Wazait et al (for which results are explain in more detail below) (22).…”

Section: Resultsmentioning

confidence: 87%

“…Three of the studies were qualitative studies whereby clinicians were given questionnaires to complete (14,19,22). Two of these were conducted within the UK whilst the other was a pan-European study.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Endoscopic surveillance for bladder cancer: a systematic review of contemporary worldwide practices

Russell¹,

Kotecha²,

Thurairaja³

et al. 2021

Transl Androl Urol

View full text Add to dashboard Cite

Background: The aim of this systematic review was to identify the current endoscopic surveillance strategies in use across the world and to determine whether these were sufficient or if any recommendations for changes in the guidelines could be made. This review focused on the cystoscopic follow-up of nonmuscle invasive bladder cancer (NMIBC) patients and muscle invasive bladder cancer (MIBC) patients who had undergone bladder sparing treatments.Methods: A literature search was carried out on Medline and Embase using OVID gateway according to a pre-defined protocol. Systematic screening of the identified studies was carried out by two authors. Quality assessment was performed using the Joanna Briggs critical appraisal tools. Data was extracted on various aspects including the follow-up regime utilised, patients included, outcomes investigated and a summary of the results. The studies were compared in a narrative nature.Results: A total of 2,604 studies were identified from the search strategy, of which 14 were deemed suitable for inclusion following the screening process. The studies identified were from nine countries and were mainly observational or qualitative. There was a huge variation in the follow-up regimes utilised within the studies with no clear consensus as to which regime was the most suitable. However, all studies utilised an initial cystoscopy at three months post-TURBT. No studies were identified which investigated the endoscopic follow-up strategies for MIBC patients who opted for bladder conservation with chemoradiation.Conclusions: There is no universally accepted protocol for endoscopic follow-up of patients with NMIBC bladder cancer. Guidance on cystoscopic monitoring of bladder in patients who have undergone chemoradiation for MIBC is also lacking.

show abstract

Section: Discussionmentioning

confidence: 58%

Section: Resultsmentioning

confidence: 76%

Section: Resultsmentioning

confidence: 87%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations